改良耳鸣缓解声(MTRS)治疗慢性耳鸣的临床效果:随机对照试验方案
本研究为随机双盲对照临床试验,计划招募68例慢性主观性耳鸣患者,按1:1随机分为改良耳鸣缓解声(MTRS)组和未改良音乐(UM)对照组。主要结局为耳鸣残疾量表(THI),次要结局包括医院焦虑抑郁量表(HADS)、雅典失眠量表(AIS)、耳鸣视觉模拟量表(VAS)及感觉级匹配的耳鸣响度。评估在基线及随机化后1、3、9、12个月进行,声音刺激持续至随机化后9个月,最后3个月停止。
要点
- MTRS是一种新型声学疗法,本研究将其与未改良音乐对照,评估对慢性主观性耳鸣的疗效。
- 主要结局为THI,次要结局包括HADS(含焦虑和抑郁亚量表)、AIS、耳鸣VAS及感觉级匹配的耳鸣响度。
- 评估时间点为基线及随机化后1、3、9、12个月,声音刺激持续至9个月,最后3个月停止。
核心结论
- 本研究旨在介绍新型声学疗法MTRS,并评估其与未改良音乐相比对慢性主观性耳鸣的疗效。
研究设计与样本
- 随机、双盲、对照临床试验,计划招募68例主观性耳鸣患者,按1:1比例随机分配至两组。
主要发现
- 原文未报告研究结果。
关键数值与推荐
- 主要结局为耳鸣残疾量表(THI)。
- 次要结局为医院焦虑抑郁量表(HADS;含焦虑亚量表HADS-A和抑郁亚量表HADS-D)、雅典失眠量表(AIS)、耳鸣视觉模拟量表(VAS)及感觉级(SL)匹配的耳鸣响度。
- 评估在基线及随机化后1、3、9、12个月进行。
- 声音刺激持续至随机化后9个月,最后3个月停止。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Chronic subjective tinnitus has become an increasingly serious hazard that affects the health-related quality of life for millions of people. Due to the lack of curative treatment strategies, this study aims to introduce a novel acoustic therapy named the modified tinnitus relieving sound (MTRS) for tinnitus and to evaluate the efficacy of MTRS in comparison with unmodified music (UM) which served as a control. METHODS AND ANALYSIS: A randomized, double-blinded, controlled, clinical trial will be carried out. Sixty-eight patients with subjective tinnitus will be recruited and randomly allocated into two groups in 1:1 ratio. The primary outcome is Tinnitus Handicapped Inventory (THI); the secondary outcomes are the Hospital Anxiety and Distress Scale (HADS; HADS subscales for Anxiety (HADS-A) and Depression (HADS-D)), Athens Insomnia Scale (AIS), the visual analog scale (VAS) for tinnitus, and tinnitus loudness matched by sensation level (SL). Assessment will be performed at baseline and at 1, 3, 9, and 12 months post-randomization. The sound stimulus will be persistent until 9 months after randomization, and be interdictory in the last three months. Data collected during the intervention process will be analyzed and compared to baseline. ETHICS AND DISSEMINATION: This trial received ethical approval from the Institutional Review Board (IRB) of Eye & ENT Hospital of Fudan University (No. 2017048). The study results will be disseminated via academic journals and conferences. FUNDING: This study is supported by the Shanghai Shenkang Development Program (SHDC12019119), the Excellent Doctors-Excellent Clinical Researchers Program (SYB202008), the Shanghai Rising-Star Program (23QC1401200), the Shanghai Rising Stars of Medical Talent Youth Development Program (2021-99), the National Natural Science Foundation of China (81800912), and the National Natural Science Foundation of Shanghai (21ZR1411800). TRIAL REGISTRATION: ClinicalTrials.gov NCT04026932. Registered on 18 July 2019.
引用
- Tang D, Wang J, Yu X, et al. The clinical effects of modified tinnitus relieving sound (MTRS) for chronic tinnitus: protocol for a randomized controlled trial. Trials. 2023. PMID: 37268971. doi:10.1186/s13063-023-07389-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。